VivoSeq
Other

Fecal Microbiota Transplantation

0

Pipeline Programs

15

Active Trials

0

Companies Involved

Fecal Microbiota Transplantation is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

32/100

Pipeline Velocity

19/100

Mech. Concentration

N/A

Completion Rate

67/100

Attrition Rate

16/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

37

clinical trials

Completed12 · 32%
Recruiting10 · 27%
Unknown status4 · 11%
Not yet recruiting4 · 11%
Withdrawn3 · 8%
Terminated3 · 8%
Other1 · 3%

Trial Activity

37 trials

Fecal Microbiota Transplantation in Kidney Stone Patients
Recruiting··Phase 1·NCT05516472·36 enrolled
Fecal Microbiota Transplantation for IBS
Recruiting·MMadhusudan (Madhu) Grover, MBBS·Phase 2·NCT05776914·43 enrolled
Fecal Microbiota Transplantation for Steroid-Refractory Acute GI GVHD
Not yet recruiting··Phase 2·NCT07364617·35 enrolled
Evaluation of the Outcome of Fecal Microbiota Transplantation
Not yet recruiting··Phase 1/2·NCT07454408·40 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)